According to the FDA, some Wallcur training IV products have been distributed to healthcare facilities and used on patients. The use of one such product in particular, Practi IV Solution Bags, has been associated with serious adverse events.
The FDA asks providers to report any incidents of use of Wallcur training IV products on patients to the MedWatch Adverse Event Reporting program. Find more information here.
More articles on patient safety:
CIO Dr. Pravene Nath: Combining patient safety with IT
CMS extends TB exposure compliance deadline for Providence Memorial in El Paso
10 most popular patient safety tools of 2014
